Delta 9 Cannabis (CVE:NINE) Stock Price Up 3% – Should You Buy?

Delta 9 Cannabis Inc (CVE:NINEGet Free Report)’s share price was up 3% during mid-day trading on Thursday . The company traded as high as C$1.13 and last traded at C$1.03. Approximately 68,728 shares traded hands during mid-day trading, a decline of 41% from the average daily volume of 117,300 shares. The stock had previously closed at C$1.00.

Delta 9 Cannabis Price Performance

The company has a current ratio of 4.44, a quick ratio of 2.04 and a debt-to-equity ratio of 33.00. The company has a 50 day simple moving average of C$1.03 and a 200 day simple moving average of C$1.03. The stock has a market cap of C$89.36 million and a P/E ratio of 19.07.

About Delta 9 Cannabis

(Get Free Report)

Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.

Further Reading

Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.